A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.
A procedure assessed by NICE and used in research led by the University of Birmingham has been hailed as an "exciting development" in increasing the number of livers which can be safely used for transplantation.
University of Birmingham clinician scientist and hepatologist Dr Ye Htun Oo has been awarded £1.7 million to fund translational biomedical research into autoimmune liver diseases.
The city of Birmingham has also been awarded with Transplant Sport's first ever Donor City Award, in association with the Daily Mirror.
Study underway at University of Birmingham and Queen Elizabeth Hospital Birmingham to establish if livers that have been rejected for transplantation can be made viable by using a liver perfusion machine.